Toxoplasma dye test using cell culture derived tachyzoites

被引:25
作者
Ashburn, D [1 ]
Evans, R [1 ]
Chatterton, JMW [1 ]
Joss, AWL [1 ]
Ho-Yen, DO [1 ]
机构
[1] Raigmore Hosp, Dept Microbiol, Scottish Toxoplasma Reference Lab, Highland Acute Hosp NHS Trust, Inverness IV2 3UJ, Scotland
关键词
toxoplasma dye test; cell culture; citrate;
D O I
10.1136/jcp.53.8.630
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To assess the diagnostic usefulness of Toxoplasma gondii tachyzoites produced by serial passage in HeLa cell culture. Methods-Tachyzoites derived from serial passage in cell culture were used in the dye test. Human sera were also examined to determine their suitability for use as accessory factor. Using the optimum conditions, the dye test using cell culture derived tachyzoites was compared with the current method of production (animal culture) on 105 randomly selected sera. Start up and maintenance costs of each system were compared. Results-Tachyzoites in most cell culture harvests (84%) from both early and later passes were useable. Tachyzoite yield and viability were maintained during serial passage in cell culture. Sodium citrate was used to modify accessory factor and improve its suitability. The performance of the accessory factor was improved by the addition of 1% and 3% sodium citrate for the current and cell culture systems, respectively. Under optimum conditions, dye test titres using cell culture and current systems were compared on 105 randomly selected sera. The results from 92 of 105 (87.6%) patients agreed or were within one dilution, but all discrepancies were resolved on re-testing. Start up costs for the current system would be 2.5 times and overall maintenance three times more expensive than cell culture. Conclusions-Tachyzoites derived from cell culture can be used routinely in the dye test. Production in cell culture is more cost effective than animal culture. It is possible for general hospitals to perform the dye test, thus obtaining faster and more specific results.
引用
收藏
页码:630 / 633
页数:4
相关论文
共 9 条
[1]  
Ashburn D, 1998, J CLIN PATHOL-MOL PA, V51, P105
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   A MICROMODIFICATION OF TOXOPLASMA DYE TEST [J].
FELDMAN, HA ;
LAMB, GA .
JOURNAL OF PARASITOLOGY, 1966, 52 (02) :415-&
[4]  
FLECK DG, 1980, LAB DIAGNOSIS TOXOPL
[5]   INVITRO CULTURE OF TOXOPLASMA-GONDII IN PRIMARY AND ESTABLISHED CELL-LINES [J].
HUGHES, HPA ;
HUDSON, L ;
FLECK, DG .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1986, 16 (04) :317-322
[6]  
Joss AWL, 1992, HUMAN TOXOPLASMOSIS, P79
[7]   AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY WITH WHOLE TROPHOZOITES OF TOXOPLASMA-GONDII FROM SERUM-FREE TISSUE-CULTURE FOR DETECTION OF SPECIFIC ANTIBODIES [J].
OBWALLER, A ;
HASSL, A ;
PICHER, O ;
ASPOCK, H .
PARASITOLOGY RESEARCH, 1995, 81 (05) :361-364
[8]  
Payne R. A., 1966, Monthly Bulletin Ministry of Health, V25, P161
[9]   DYES AS MICROCHEMICAL INDICATORS OF A NEW IMMUNITY PHENOMENON AFFECTING A PROTOZOON PARASITE (TOXOPLASMA) [J].
SABIN, AB ;
FELDMAN, HA .
SCIENCE, 1948, 108 (2815) :660-663